Formulary Search Results for: BOSUTINIB
8.1.5 Other antineoplastic drugs - View Category
Total Formulary
BOSUTINIB (BOSULIF) (tablets)
Restrictions:
Use in the treatment of adults with Philadelphia chromosome positive chronic myelogenous leukaemia (Ph+ CML) previously treated with one or more tyrosine kinase inhibitor(s) and for whom imatinib, nilotinib and dasatinib are not considered appropriate, is restricted to specialist use in accordance with regional protocol.
Prescribing Notes:
The treatment of adults with newly diagnosed Philadelphia chromosome positive chronic myelogenous leukaemia (Ph+ CML) is not recommended by SMC and is non-Formulary.